Results 21 to 30 of about 1,116,148 (287)

Reversal of cardiovascular remodelling with candesartan [PDF]

open access: yesJournal of the Renin-Angiotensin-Aldosterone System, 2001
Cardiovascular remodelling, defined as ventricular and vascular hypertrophy together with fibrosis, characterises hypertension following inhibition of the production of the endogenous vasodilator, nitric oxide (NO). This study has determined whether the cardiovascular remodelling following chronic NO synthase inhibition can be reversed by ...
Brown, Lindsay   +3 more
openaire   +5 more sources

Reversed Reverse Remodeling [PDF]

open access: yesCirculation: Heart Failure, 2014
In the course of managing patients with chronic heart failure (HF) because of left ventricular systolic dysfunction (LVSD; typically defined as an LV ejection fraction [EF] ≤40–50%), the goals of care include prescription of guideline-directed medical therapy with the achievement of target doses of angiotensin-converting enzyme inhibitors or ...
James L, Januzzi, Paul J, Hauptman
openaire   +2 more sources

Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy.

open access: yesPLoS ONE, 2020
Currently, aortic valve replacement is the only treatment capable of relieving left ventricle pressure overload in patients with severe aortic stenosis.
Fábio Trindade   +6 more
doaj   +2 more sources

Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2021
Background: Compared to angiotensin inhibition, angiotensin-neprilysin “blockade” improves mortality and reduces hospitalizations in patients with heart failure (HF) with reduced ejection fraction (EF).
Carla Paolini   +6 more
doaj   +1 more source

Prediction of Left Ventricular Remodeling after a Myocardial Infarction: Role of Myocardial Deformation: A Systematic Review and Meta-Analysis. [PDF]

open access: yesPLoS ONE, 2016
Left ventricular (LV) adverse or reverse remodeling after ST-segment elevation myocardial infarction (MI) is the best outcome to assess the benefit of revascularization.
Olivier Huttin   +9 more
doaj   +1 more source

A review of biomarker and imaging monitoring to predict heart failure recovery

open access: yesFrontiers in Cardiovascular Medicine, 2023
Heart failure is a clinical syndrome caused by structural cardiac abnormalities that lead to increased intracardiac pressures and decreased cardiac output.
Crystal Lihong Yan, Luanda Grazette
doaj   +1 more source

Impact of valvuloarterial impedance on left ventricular reverse remodeling after aortic valve neocuspidization

open access: yesJournal of Cardiothoracic Surgery, 2022
Background Aortic valve neocuspidization (AVNeo) has emerged as a promising aortic valve procedure, and is expected to have a larger effective orifice area (EOA) than commercially available bioprostheses.
Naoki Yamamoto   +9 more
doaj   +1 more source

Drastic Cardiac Reverse Remodeling Following Catheter Ablation in Patients with Atrial Fibrillation and Heart Failure

open access: yesMedicina, 2021
In the management of atrial fibrillation in patients with heart failure, rate control is recommended, whereas the implication of rhythm control remains controversial.
Takahisa Koi   +3 more
doaj   +1 more source

Reversal of heart failure remodeling: Is it maintained? [PDF]

open access: yesClinical Cardiology, 2003
AbstractBackground: Reversal of heart failure remodeling has been observed with intensive heart failure therapy.Hypothesis: We hypothesized that reversal of heart failure remodeling may not be sustained in long‐term follow‐up.Methods: Sixty‐one sequential patients with heart failure and left ventricular ejection fraction ≤ 35%, who improved their ...
T Barry, Levine   +3 more
openaire   +2 more sources

ATP-dependent chromatosome remodeling [PDF]

open access: yes, 2008
Chromatin serves to package, protect and organize the complex eukaryotic genomes to assure their stable inheritance over many cell generations. At the same time, chromatin must be dynamic to allow continued use of DNA during a cell's lifetime.
Chioda, Mariacristina   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy